WallStreetZenWallStreetZen

NASDAQ: DERM
Journey Medical Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their DERM stock forecasts and price targets.

Forecast return on equity

Is DERM forecast to generate an efficient return?

Company
107.07%
Industry
47.05%
Market
88.22%
DERM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DERM forecast to generate an efficient return on assets?

Company
26.78%
Industry
18%
DERM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DERM earnings per share forecast

What is DERM's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.23
Avg 2 year Forecast
-$0.05
Avg 3 year Forecast
$0.39

DERM revenue forecast

What is DERM's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$74.5M+32.76%
Avg 2 year Forecast
$93.4M+66.42%
Avg 3 year Forecast
$122.9M+118.96%
DERM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DERM revenue growth forecast

How is DERM forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
29.17%
Industry
6.01%
Market
10.65%
DERM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DERM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DERM vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
DERM$5.92N/AN/A
BIOA$3.88$5.67+46.06%Sell
OGI$1.06N/AN/A
CGC$1.05N/AN/A
OPTN$9.14$9.00-1.53%Hold
View Top Pharmaceutical Stocks

Journey Medical Stock Forecast FAQ

What is DERM's earnings growth forecast for 2025-2027?

(NASDAQ: DERM) Journey Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 19.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.78%.

Journey Medical's earnings in 2025 is -$14,672,000.On average, 2 Wall Street analysts forecast DERM's earnings for 2025 to be -$5,314,021, with the lowest DERM earnings forecast at -$14,093,707, and the highest DERM earnings forecast at $3,465,666. On average, 1 Wall Street analyst forecast DERM's earnings for 2026 to be -$1,155,222, with the lowest DERM earnings forecast at -$1,155,222, and the highest DERM earnings forecast at -$1,155,222.

In 2027, DERM is forecast to generate $9,010,730 in earnings, with the lowest earnings forecast at $9,010,730 and the highest earnings forecast at $9,010,730.

If you're new to stock investing, here's how to buy Journey Medical stock.

What is DERM's revenue growth forecast for 2025-2027?

(NASDAQ: DERM) Journey Medical's forecast annual revenue growth rate of 29.17% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.01%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.65%.

Journey Medical's revenue in 2025 is $56,134,000.On average, 2 Wall Street analysts forecast DERM's revenue for 2025 to be $1,721,858,167, with the lowest DERM revenue forecast at $1,657,281,266, and the highest DERM revenue forecast at $1,786,435,069. On average, 1 Wall Street analysts forecast DERM's revenue for 2026 to be $2,158,416,505, with the lowest DERM revenue forecast at $2,158,416,505, and the highest DERM revenue forecast at $2,158,416,505.

In 2027, DERM is forecast to generate $2,839,766,352 in revenue, with the lowest revenue forecast at $2,839,766,352 and the highest revenue forecast at $2,839,766,352.

What is DERM's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: DERM) forecast ROA is 26.78%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 18%.

What is DERM's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: DERM) Journey Medical's current Earnings Per Share (EPS) is -$0.72. On average, analysts forecast that DERM's EPS will be -$0.23 for 2025, with the lowest EPS forecast at -$0.61, and the highest EPS forecast at $0.15. On average, analysts forecast that DERM's EPS will be -$0.05 for 2026, with the lowest EPS forecast at -$0.05, and the highest EPS forecast at -$0.05. In 2027, DERM's EPS is forecast to hit $0.39 (min: $0.39, max: $0.39).

What is DERM's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: DERM) forecast ROE is 107.07%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.